Sandu Pharmaceuticals Reports Q2 FY27 Financial Results
Sandu Pharmaceuticals Ltd · Financial Result · 15 Nov 2026, 12:27 am
Sandu Pharmaceuticals Reports Q2 FY27 Financial Results For the quarter ended 30th Sep'26, Sandu Pharmaceuticals posted revenue from operations of ₹1,942.88 lakhs, up 10.26% YoY from ₹1,762.11 lakhs and 18.55% QoQ from ₹1,638.88 lakhs. Net profit rose 49.76% YoY to ₹78.52 lakhs versus ₹52.43 lakhs in the previous year quarter, with basic EPS increasing to ₹0.81 from ₹0.54. For the half-year ended 30th Sep'26, revenue stood at ₹3,581.76 lakhs compared to ₹3,432.01 lakhs YoY, while net profit grew 35.56% YoY to ₹101.35 lakhs from ₹74.76 lakhs.
Original exchange filing (PDF)
More announcements from Sandu Pharmaceuticals Ltd
- statement of deviation and variation of funds for q ended 30th sept 2026 · 15 Nov 2026
- Outcome of the Board Meeting dated 14th November 2026 · 15 Nov 2026
- Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Approval of Unaudited .... · 14 Nov 2026
- Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta · 09 Oct 2026
- Intimation to the holders of Physical Securities to furnish PAN and KYC details · 30 Sept 2026
- 1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director · 12 Sept 2026
- Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting · 12 Sept 2026
- 41st Annual General Meeting scrutinizers Report · 12 Sept 2026
